ResMed (RMD) Form 144: insider plans $524K Rule 144 sale

Rhea-AI Filing Summary

ResMed Inc. insider plans sale of common shares under Rule 144. The notice covers a proposed sale of 2,055 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $524,025.00. The issuer has 145,966,294 common shares outstanding. The shares derive from restricted stock vesting awards granted as compensation on 11/11/2021 and 11/11/2024.

During the past three months, the same seller, Jan De Witte, sold 487 common shares on 11/11/2025 for gross proceeds of $121,871.75. By signing the notice, the seller represents that he does not know any material adverse information about ResMed’s current or prospective operations that has not been publicly disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2055	524025.00	145966294	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2021	Restricted Stock Vesting	Issuer			1083	11/11/2021	Compensation
Common	11/11/2024	Restricted Stock Vesting	Issuer			972	11/11/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jan De Witte 9001 Spectrum Center Blvd. San Diego CA 92123	Common	11/11/2025	487	121871.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ResMed (RMD) Form 144 filed by Jan De Witte disclose?

The Form 144 indicates that insider Jan De Witte plans to sell 2,055 ResMed common shares on the NYSE through Fidelity Brokerage Services LLC under Rule 144.

How many ResMed (RMD) shares are covered by this planned Rule 144 sale?

The notice covers a proposed sale of 2,055 common shares of ResMed, with an aggregate market value of $524,025.00 as stated in the filing.

How many ResMed (RMD) shares has the insider sold recently?

Over the past three months, the seller reported a sale of 487 common shares of ResMed on 11/11/2025, generating $121,871.75 in gross proceeds.

What is the source of the ResMed (RMD) shares being sold under this Form 144?

The shares come from restricted stock vesting granted as compensation from the issuer, with vesting dates of 11/11/2021 and 11/11/2024, totaling 1,083 and 972 shares respectively.

How many ResMed (RMD) shares are outstanding compared with the planned sale?

The filing states that 145,966,294 common shares of ResMed are outstanding, providing context for the planned sale of 2,055 shares under Rule 144.

What representation does the insider make in this ResMed (RMD) Form 144?

By signing, the seller represents that he does not know any material adverse information about ResMed’s current or prospective operations that has not been publicly disclosed.